Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Novartis reports second quarter earnings

Novartis (NVS; SWX:NOVN) reported second quarter earnings per ADS of $0.53, up 4% from

Read the full 143 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE